We are live on ! Find out more
Cambridge Investment Research Advisors

Cambridge Investment Research Advisors Portfolio holdings

AUM $44.6B
1-Year Est. Return 28.94%
This Fund
S&P 500
This Quarter Est. Return
+6.8%
1 Year Est. Return
+28.94%
3 Year Est. Return
+82.62%
5 Year Est. Return
+90.41%
10 Year Est. Return
+293.66%
AUM
$20.4B
AUM Growth
+$1.11B
Cap. Flow
+$100M
Cap. Flow %
0.49%
Top 10 Hldgs %
18.19%
Holding
3,316
New
217
Increased
1,367
Reduced
1,468
Closed
167

Sector Composition

Rank Sector Weight
1 Technology 9.45%
2 Financials 4.68%
3 Healthcare 4.07%
4 Consumer Discretionary 3.92%
5 Industrials 2.97%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
APPS icon
3151
Digital Turbine
APPS
$1.5B
-15,711
Closed -$239K
ARCO icon
3152
Arcos Dorados Holdings
ARCO
$1.66B
-10,050
Closed -$84K
AREC icon
3153
American Resources Corp
AREC
$300M
-17,982
Closed -$24K
ASB icon
3154
Associated Banc-Corp
ASB
$6.07B
-9,254
Closed -$214K
BANR icon
3155
Banner Corp
BANR
$2.5B
-3,287
Closed -$208K
BBVA icon
3156
Banco Bilbao Vizcaya Argentaria
BBVA
$157B
-16,538
Closed -$99K
BCS icon
3157
Barclays
BCS
$94.4B
-10,219
Closed -$80K
BEAM icon
3158
Beam Therapeutics
BEAM
$2.76B
-5,658
Closed -$221K
BLMN icon
3159
Bloomin' Brands
BLMN
$975M
-14,464
Closed -$291K
BPT
3160
DELISTED
BP Prudhoe Bay Royalty Trust
BPT
-11,703
Closed -$137K
BRTX icon
3161
BioRestorative Therapies
BRTX
$5.41M
-28,050
Closed -$77K
STEX
3162
Streamex Corp
STEX
$87.3M
-41,159
Closed -$173K
CARM
3163
DELISTED
Carisma Therapeutics
CARM
-4,741
Closed -$58K
CMRE icon
3164
Costamare
CMRE
$1.71B
-32,844
Closed -$305K
CNK icon
3165
Cinemark Holdings
CNK
$4.32B
-10,112
Closed -$88K
CPNG icon
3166
Coupang
CPNG
$29.3B
-12,988
Closed -$191K
CPRX
3167
DELISTED
Catalyst Pharmaceutical
CPRX
-21,457
Closed -$399K
CRBP icon
3168
Corbus Pharmaceuticals
CRBP
$189M
-2,225
Closed -$7K
CSTL icon
3169
Castle Biosciences
CSTL
$960M
-12,501
Closed -$294K
CTBI icon
3170
Community Trust Bancorp
CTBI
$1.42B
-4,880
Closed -$224K
DAN icon
3171
Dana Inc
DAN
$3.2B
-68,415
Closed -$1.03M
DB icon
3172
Deutsche Bank
DB
$72.4B
-65,326
Closed -$753K
DMA
3173
Destra Multi-Alternative Fund
DMA
$68.7M
-13,737
Closed -$94K
EBC icon
3174
Eastern Bankshares
EBC
$5.34B
-105,900
Closed -$1.83M
EC icon
3175
Ecopetrol
EC
$34.9B
-12,273
Closed -$129K

Similar funds

Cambridge Investment Research Advisors's Q1 2023 Portfolio in Review

As of Q1 2023, Cambridge Investment Research Advisors held 3,316 positions worth $20.4B, up 5.8% from $19.3B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Cambridge Investment Research Advisors's Q1 2023 filing shows 217 new, 1,367 increased, 1,468 reduced and 167 closed positions. Its largest new stake was State Street SPDR Bloomberg International Treasury Bond ETF: 735,671 shares worth $17M. The largest sale was iShares 0-1 Year Treasury Bond ETF, an estimated $44.6M.

By sector, the portfolio is most concentrated in Technology at 9.4% of assets, up from 8% a quarter earlier, followed by Financials and Healthcare.

  • Cambridge Investment Research Advisors's largest Q1 2023 buy was State Street SPDR Bloomberg International Treasury Bond ETF: 735,671 shares worth $17M.
  • Cambridge Investment Research Advisors added most to State Street SPDR Bloomberg 1-3 Month T-Bill ETF in Q1 2023, an estimated $43.9M increase.
  • Cambridge Investment Research Advisors's biggest Q1 2023 reduction was iShares 0-1 Year Treasury Bond ETF, cutting an estimated $44.6M.
  • Cambridge Investment Research Advisors fully exited ProShares Short Russell2000 in Q1 2023, selling an estimated $4.61M.
  • Cambridge Investment Research Advisors's ten largest holdings make up 18% of its $20.4B portfolio in Q1 2023.
  • Cambridge Investment Research Advisors opened 217 new positions and closed 167 in Q1 2023.
  • Cambridge Investment Research Advisors's portfolio value rose 5.8% quarter-over-quarter to $20.4B.

Based on Cambridge Investment Research Advisors's 13F filing for Q1 2023, filed 11 May 2023.